Yurong Gu

1.0k total citations
63 papers, 750 citations indexed

About

Yurong Gu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yurong Gu has authored 63 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Hepatology and 22 papers in Surgery. Recurrent topics in Yurong Gu's work include Hepatitis B Virus Studies (23 papers), Head and Neck Surgical Oncology (19 papers) and Hepatitis C virus research (16 papers). Yurong Gu is often cited by papers focused on Hepatitis B Virus Studies (23 papers), Head and Neck Surgical Oncology (19 papers) and Hepatitis C virus research (16 papers). Yurong Gu collaborates with scholars based in China, United States and Oman. Yurong Gu's co-authors include Yuehua Huang, Lubiao Chen, Xicai Sun, Yubao Zheng, Yanlin Huang, Dehui Wang, Quan Liu, Lin Gu, Yifan Lian and Zhiliang Gao and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecular Cancer.

In The Last Decade

Yurong Gu

56 papers receiving 746 citations

Peers

Yurong Gu

SURGE

EPIDE

PRM

HEPAT

Yukiyasu Takeuchi Japan

Rachel Sheridan United States

Limei Qu China

Jan M. Van Tornout United States

Soumyajit Roy United States

Bryan Lin United States

E. Patsouris Greece

Józef Kobos Poland

Zofia Kołosza Poland

Yukiyasu Takeuchi Japan

Yurong Gu

258 ×1.2

SURGE

211 ×1.0

EPIDE

193 ×1.0

561 ×3.2

PRM

11 ×0.1

HEPAT

Citations per year, relative to Yurong Gu Yurong Gu (= 1×) peers Yukiyasu Takeuchi

Countries citing papers authored by Yurong Gu

Since Specialization

Citations

This map shows the geographic impact of Yurong Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yurong Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yurong Gu more than expected).

Fields of papers citing papers by Yurong Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yurong Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yurong Gu. The network helps show where Yurong Gu may publish in the future.

Co-authorship network of co-authors of Yurong Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yurong Gu. A scholar is included among the top collaborators of Yurong Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yurong Gu. Yurong Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Wanpeng, Tian Wang, Quan Liu, et al.. (2025). Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: a randomized clinical trial. Journal for ImmunoTherapy of Cancer. 13(5). e011998–e011998.

Li, Wanpeng, Kai Xue, Haoran Yu, et al.. (2024). ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma. Non-coding RNA Research. 10. 116–129. 3 indexed citations

Li, Xiaofeng, et al.. (2024). ACSL4 accelerates osteosarcoma progression via modulating TGF-β/Smad2 signaling pathway. Molecular and Cellular Biochemistry. 480(1). 549–562. 3 indexed citations

Zhang, Xiaoyu, Shanshan Li, Yurong Gu, et al.. (2024). CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p/NUPR1/FTH1 axis. Molecular Cancer. 23(1). 113–113. 35 indexed citations

Gu, Yurong, et al.. (2024). USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches. PeerJ. 12. e17397–e17397. 4 indexed citations

Gu, Yurong, et al.. (2024). A comprehensive model to better screen out antiviral treatment candidates for chronic hepatitis B patients. International Immunopharmacology. 140. 112848–112848.

Chen, Dongmei, Xinru Chen, Yurong Gu, et al.. (2024). COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling. Cellular Oncology. 47(5). 1897–1910. 1 indexed citations

Liu, Quan, Xicai Sun, Han Li, et al.. (2021). Types of Transnasal Endoscopic Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma: Shanghai EENT Hospital Experience. Frontiers in Oncology. 10. 555862–555862. 21 indexed citations

Lu, Hanyu, Huan Wang, Yurong Gu, et al.. (2021). Clinical Outcomes of Salvage Endoscopic Nasopharyngectomy for Patients With Advanced Recurrent Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 716729–716729. 17 indexed citations

10.

Lu, Hanyu, Huan Wang, Xianhui Ning, et al.. (2020). Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107. Cancer Letters. 499. 301–313. 38 indexed citations

11.

Li, Wanpeng, Hanyu Lu, Juan Liu, et al.. (2020). Quality of Life Following Salvage Endoscopic Nasopharyngectomy in Patients With Recurrent Nasopharyngeal Carcinoma: A Prospective Study. Frontiers in Oncology. 10. 437–437. 11 indexed citations

12.

Gu, Yurong, Lubiao Chen, Yifan Lian, et al.. (2019). Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients. Journal of Medical Virology. 92(3). 317–328. 15 indexed citations

13.

Li, Xiaoyan, Liang Zhou, Yurong Gu, et al.. (2019). Quantative HBsAg level correlates dendritic cells maturation in chronic hepatitis B patients. Clinics and Research in Hepatology and Gastroenterology. 44(3). 321–328. 4 indexed citations

14.

Huang, Yanlin, Gang Ning, Lubiao Chen, et al.. (2019). <p>Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma</p>. Cancer Management and Research. Volume 11. 1725–1740. 43 indexed citations

15.

Chen, Long, et al.. (2019). The Clinical Effect of Arthroscopic Rotator Cuff Repair techniques: A Network Meta-Analysis and Systematic Review. Scientific Reports. 9(1). 4143–4143. 11 indexed citations

16.

Liu, Juan, et al.. (2018). Endoscopic sequestrectomy for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a 10‑year experience. International Journal of Clinical Oncology. 24(3). 248–255. 20 indexed citations

17.

Wang, Dehui, Xicai Sun, Jingjing Wang, et al.. (2018). Cumulative sum analysis of the learning curve for endoscopic resection of juvenile nasopharyngeal angiofibroma. Surgical Endoscopy. 32(7). 3181–3191. 14 indexed citations

18.

Chen, Lubiao, Lin Gu, Yurong Gu, et al.. (2016). HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression. Scientific Reports. 6(1). 35917–35917. 9 indexed citations

19.

Zheng, Yubao, Yurong Gu, Min Zhang, et al.. (2015). Health care workers in Pearl River Delta Area of China are not vaccinated adequately against hepatitis B: a retrospective cohort study. BMC Infectious Diseases. 15(1). 542–542. 11 indexed citations

20.

Liu, Quan, Jing Ye, Hongmeng Yu, et al.. (2010). Survival-enhancing of spiral ganglion cells under influence of olfactory ensheathing cells by direct cellular contact. Neuroscience Letters. 478(1). 37–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact